TITLE

Birth Defects

AUTHOR(S)
McGlannan, Frances; Wilson, James
PUB. DATE
December 1973
SOURCE
Journal of Learning Disabilities;Dec1973, Vol. 6 Issue 10, p617
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the effects of drugs and environmental chemicals taken during pregnancy. Drugs taken during the first trimester account for a very minor proportion of birth abnormalities. However, simultaneous exposure to interacting drugs or chemicals probably causes many of the poorly understood fetal defects. A few drugs, such as sulfonamides, cortisone, antiemetics, and most tranquilizers, have been used so extensively during pregnancy without causing defects, that they can be assumed to have little or no teratogenic risk. The ubiquitous food preservative benzoic acid and aspirin interact metabolically in man and it has been found that the teratogenic effect of an aspirin dose in rats can be increased by administering benzoic acid concurrently. Organic mercury is also a known teratogen, as are all anticonvulsants. The sulfonylurea hypoglycemic agents should be viewed suspiciously with regard to their teratogenic potential. Alkylating agents are suspect because of their polyfunctional suppression of growth.
ACCESSION #
19031926

 

Related Articles

  • Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks. van Gelder, Marleen M. H. J.; de Jong-van den Berg, Lolkje T. W.; Roeleveld, Nel // Human Reproduction;Jan2014, Vol. 29 Issue 1, p168 

    STUDY QUESTION What is the current state of knowledge on the human risks of drugs suspected to be associated with teratogenic mechanisms? SUMMARY ANSWER Evidence for the presence or absence of human risks of birth defects is scarce or non-existent for the majority of drugs associated with...

  • Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998–2009. van Gelder, Marleen M.H.J.; Bos, Jens H.J.; Roeleveld, Nel; de Jong-van den Berg, Lolkje T.W. // Human Reproduction;Jan2014, Vol. 29 Issue 1, p161 

    STUDY QUESTION What are the dispensing rates of drugs suspected to be associated with teratogenic mechanisms among pregnant Dutch women? SUMMARY ANSWER In a substantial proportion of pregnancies in our study population at least one drug associated with a teratogenic mechanism was dispensed in...

  • In utero exposure to antivirals not found to increase birth defects.  // Reactions Weekly;9/4/2010, Issue 1317, p1 

    The article offers information on a study, published in the "Journal of the American Medical Association," which revealed that first-trimester in utero exposure to aciclovir or valaciclovir does not lead to an increased risk of major birth defects. An accompanying editorial found the results to...

  • Postmarketing Analysis of Medicines: Methodology and Value of the Spanish Case-Control Study and Surveillance System in Preventing Birth Defects. Luisa, Maria; Martínez-Frías // Drug Safety;2007, Vol. 30 Issue 4, p307 

    There are many surveillance systems of congenital defects all over the world; several of them have developed specific approaches to generate and test selected hypotheses regarding human teratogens. However, to the best of our knowledge, none of them have a permanent and systematised programme...

  • In utero lamotrigine exposure linked to cleft palate/lip.  // Reactions Weekly;8/5/2006, Issue 1113, p2 

    The article focuses on a study which found that in utero exposure to lamotrigine during the first trimester of pregnancy may be associated with an increased risk of developing cleft palate and cleft lip. The approximate occurrence of cleft palate/cleft lip in the general population is mentioned....

  • No black and white answer to SSRI teratogenicity question.  // Reactions Weekly;7/7/2007, Issue 1159, p5 

    This article focuses on a study which examined the association between first-trimester use of selective serotonin reuptake inhibitors (SSRI) and birth defects. An overview of the study population is presented, as well as a description of the methodology. Results revealed that maternal use of...

  • Gestación exitosa después de exposición inadvertida a ciclofosfamida durante el primer trimestre en una paciente con lupus activo. Reporte de caso. Escobar, Mauricio Restrepo // Iatreia;Sep2011, Vol. 24 Issue 3, p320 

    Cyclophosphamide should be avoided during pregnancy because of its known teratogenic effects. Embryos or fetuses of mothers who require the use of this drug or who have been inadvertently exposed to it usually have an adverse outcome. However, successful pregnancies have occasionally been...

  • Developmental Defects: A Final Common Pathway of Teratogenicity? Goldman, Allen S. // Clinical Pediatrics;Nov1973, Vol. 12 Issue 11, p627 

    Comments on the developmental defects of fetus caused by teratogenic agents. Diseases associated with leukocytosis; Common pathway of teratogenic agents; Speculations on the neurohormonal effects of the teratogens which may alter tissue permeability; Administration of sodium bicarbonate to...

  • Adverse Effects with Isotretinoin.  // Clinical Pediatrics;Jun1984, Vol. 23 Issue 6, p344 

    Discusses the side effects of the drug isotretinoin (Accutane) which is contraindicated for use in pregnancy. Animal teratogenicity; Reports of adverse experiences in patients using this drug; Labeling as "Pregnancy Category X"; Abortions and birth defects as a result of women taking...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics